DOI: 10.1128/mBio.00230-20
Article Information
PubMed
Published By
History
- Received February 5, 2020
- Accepted March 16, 2020
- Published online April 7, 2020.
Copyright & Usage
Copyright © 2020 Birštonas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Gustavo H. Goldman, Editor, Universidade de São Paulo
Author Information
- Lukas Birštonasa,
- Alex Dallemullea,
- Manuel S. López-Bergesa*,
- Ilse D. Jacobsenb,
- Martin Offterdingerc,
- Beate Abta,
- Maria Straßburgerd,
- Ingo Bauera,
- Oliver Schmidte,
- Bettina Sargf,
- Herbert Lindnerf,
- Hubertus Haasa,
- Fabio Gsallera
- aInstitute of Molecular Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria
- bResearch Group Microbial Immunology, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany
- cInstitute of Neurobiochemistry/Biocenter, Innsbruck Medical University, Innsbruck, Austria
- dTransfer Group of Antiinfectives, Leibniz Institute for Natural Product Research and Infection Biology-Hans Knöll Institute, Jena, Germany
- eInstitute of Cell Biology/Biocenter, Innsbruck Medical University, Innsbruck, Austria
- fInstitute of Clinical Biochemistry/Biocenter, Innsbruck Medical University, Innsbruck, Austria
- Address correspondence to Fabio Gsaller, fabio.gsaller{at}i-med.ac.at.
↵* Present address: Manuel S. López-Berges, Department of Genetics, University of Córdoba, Córdoba, Spain.
Citation Birštonas L, Dallemulle A, López-Berges MS, Jacobsen ID, Offterdinger M, Abt B, Straßburger M, Bauer I, Schmidt O, Sarg B, Lindner H, Haas H, Gsaller F. 2020. Multiplex genetic engineering exploiting pyrimidine salvage pathway-based endogenous counterselectable markers. mBio 11:e00230-20. https://doi.org/10.1128/mBio.00230-20.
